Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M. Learoyd
Antitumor Activity in RAS-Driven Tumors by Blocking AKT and MEK
Clinical Cancer Research
Cancer Research
Oncology
Related publications
RAF Dimer Inhibition Enhances the Antitumor Activity of MEK Inhibitors in K‐RAS Mutant Tumors
Molecular Oncology
Cancer Research
Medicine
Oncology
Genetics
Molecular Medicine
MEK Inhibition Induces Differentiation in RAS-Driven Rhabdomyosarcoma
Cancer Discovery
Oncology
Modulation of the Akt/Ras/Raf/Mek/Erk Pathway by A3 Adenosine Receptor
Purinergic Signalling
Molecular Neuroscience
Cell Biology
Molecular Biology
Cellular
Antitumor Properties of RAF709, a Highly Selective and Potent Inhibitor of RAF Kinase Dimers, in Tumors Driven by Mutant RAS or BRAF
Cancer Research
Cancer Research
Oncology
Ras/Mek Signaling Suppresses Myc-Dependent Apoptosis in Cells Transformed by C-Myc and Activated Ras
Oncogene
Cancer Research
Genetics
Molecular Biology
Blocking P53 Aggregation Restores Its Activity and Suppresses Tumors
Cancer Discovery
Oncology
Larotrectinib Has Antitumor Activity in TRK + Pediatric Solid Tumors
Cancer Discovery
Oncology
Syndecan-1 Suppresses Cell Growth and Migration via Blocking JAK1/STAT3 and Ras/Raf/Mek/Erk Pathways in Human Colorectal Carcinoma Cells
BMC Cancer
Cancer Research
Oncology
Genetics
Antitumor Activity of MEK and PI3K Inhibitors Against Malignant Pleural Mesothelioma Cells in Vitro and in Vivo
International Journal of Oncology
Cancer Research
Oncology